ENO2 and neuroblastoma: Figure 1a-c; Table 1 demonstrate that children with neuroblastoma recurrence had significantly higher levels of serum CA125, NSE, and 24-hour urine VMA compared to those without neuroblastoma recurrence (p < 0.05).